Dibutylamine → HCID 20505824、化合物
反応式
[CH2:1]([NH:5][CH2:6][CH2:7][CH2:8][CH3:9])[CH2:2][CH2:3][CH3:4].[Cl:10][C:11]1[C:19]([S:20](Cl)(=[O:22])=[O:21])=[CH:18][C:14]([C:15]([OH:17])=[O:16])=[CH:13][CH:12]=1>C(Cl)Cl>[Cl:10][C:11]1[C:19]([S:20](=[O:22])(=[O:21])[N:5]([CH2:6][CH2:7][CH2:8][CH3:9])[CH2:1][CH2:2][CH2:3][CH3:4])=[CH:18][C:14]([C:15]([OH:17])=[O:16])=[CH:13][CH:12]=1参加物
4
実験手順
To a solution of 3.9 g. (0.03 mole) of di-n-butylamine in 15 ml. of methylene chloride is added 2.5 g. (0.01 mole) of 4-chloro-5-chlorosulfonylbenzoic acid (J. Pharm. Pharmacol., 683 (1962), and the resulting reaction mixture allowed to stir at room temperature for 3 hrs. The solvent is removed under reduced pressure and the residue partitioned between 1 N sodium hydroxide and diethyl ether. The aqueous phase is separated, acidified with 12 N hydrochloric acid and the precipitated solid filtered and dried, 3.0 g., m.p. 93°-96° C. Recrystallization from ether-hexane provides the pure product, 2.5 g., m.p. 94.5°-96.5° C.
後処理
- custom, 683 (1962), and the resulting reaction mixture
- customThe solvent is removed under reduced pressure
- customthe residue partitioned between 1 N sodium hydroxide and diethyl ether
- customThe aqueous phase is separated
- filtrationthe precipitated solid filtered
- customdried
- customRecrystallization from ether-hexane
- customprovides the pure product, 2.5 g
出典と根拠
- ORDレコード
- ord-d72a135ac3a14b39a2a7bdeada7e4f59
- 出典データセット
- uspto-grants-1983_03
- 特許番号
- US04377521
反応ノート
読み込み中…